gricertine

brain phospholipids containing the following: lysophosphatidyl choline 6%; sphingomyelin 12%; phosphatidyl choline 47%; phosphatidyl ethanolamine,-serine 30%; phosphatidic acid 5%

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/01/1975 - "Gricertine is also able to remove clinical symptoms of allergic encephalomyelitis in rats. " 05/01/1975 - "It is supposed that the protective effect of Gricertine on the allergic encephalomyelitis is based on its histamine-liberator properties which can occur during the first days of therapy: this would explain the large decrease of the brain histamine after 3 weeks of treatment. " 05/01/1975 - "A new preparation which contains specific brain phospholipids (Gricertine) acts as a histamine liberator in CNS and protects rats from allergic encephalomyelitis. "

Related Drugs and Biologics

1.	Phospholipids (Phosphatides)
2.	Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1.	Therapeutics